AriBio’s AR1001 Alzheimer’s pill slows decline in one group
A once-daily Alzheimer's pill slowed decline by 31% in patients taking it alone, but missed in the full Phase 3 trial of 1,535 people. It is not approved.
Section
A once-daily Alzheimer's pill slowed decline by 31% in patients taking it alone, but missed in the full Phase 3 trial of 1,535 people. It is not approved.
The FDA approved Genentech's Wilserdly, a daily pill, with everolimus for some adults with advanced ER-positive breast cancer that carries an ESR1 mutation.
An alert by CDC scientists counted 112 confirmed measles cases in pregnancy and 13 babies born with congenital measles since the start of 2025.
Six months after it was declared, the outbreak has more than 11,000 cases. Africa CDC's chief called it serious, while the WHO says spread is slowing in some early hot spots.
The Republican chair of the Senate health committee said on CBS that Kennedy's recent remarks cover "a series of failures" and that he still has questions about the FDA nominee.